Maurice Steenhuis

Sanquin

Papers

1

Total Citations

17

H-Index

1

About

Dr. Maurice Steenhuis is a leading immunologist whose work has been pivotal in the fight against COVID-19, particularly through the lens of antibody-based therapies. His primary research focuses on humoral immunity, convalescent plasma therapy, and the characterization of antibody responses to viral infections. Dr. Steenhuis made a critical early contribution to the pandemic response with his highly cited commentary on evaluating SARS-CoV-2 antibody titers and potency for convalescent plasma donation, a work that has garnered 17 citations and helped establish essential guidelines for plasma collection. Beyond this, his research has advanced our understanding of how to measure and ensure the neutralizing capacity of therapeutic antibodies, directly impacting patient treatment protocols. His work bridges the gap between basic immunology and clinical application, providing actionable insights for both researchers and healthcare providers. Dr. Steenhuis’s expertise in antibody assessment continues to inform strategies for pandemic preparedness and the development of effective immunotherapies, making him a key voice in the field of infectious disease immunology.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
17 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Sanquin

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago